Julien Bradley

Chief Executive Officer at RedShift BioAnalytics, Inc.

Julien Bradley

Julien Bradley

Chief Executive Officer at RedShift BioAnalytics, Inc.

Overview
Career Highlights

RedShift BioAnalytics, Inc.

RelSci Relationships

1988

Contact Data
Trying to get in touch with Julien Bradley? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Julien Bradley likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at RedShift BioAnalytics, Inc.

Relationship likelihood: Strong

Founder at Technology Venture Partners LLC

Relationship likelihood: Strong

Co-Founder at RedShift BioAnalytics, Inc.

Relationship likelihood: Strong

Chief Commercial Officer at RedShift BioAnalytics, Inc.

Relationship likelihood: Strong

Vice President-Engineering at RedShift BioAnalytics, Inc.

Relationship likelihood: Average

Professional at Wallack Investment Group LLC

Relationship likelihood: Average

Chairman at Mutual Capital Partners

Relationship likelihood: Average

Director at RedShift BioAnalytics, Inc.

Relationship likelihood: Average

Co-Founder at WestBridge Capital US Advisors LLC

Relationship likelihood: Average

Co-Founder at Vesbridge Partners LLC

Relationship likelihood: Average

Paths to Julien Bradley
Potential Connections via
Relationship Science
You
Julien Bradley
Chief Executive Officer at RedShift BioAnalytics, Inc.
Education
MBA Business Administration & Management, General

The Tuck School of Business at Dartmouth is the graduate business school of Dartmouth College in Hanover, New Hampshire, in the United States. Tuck is one of six Ivy league business schools. Founded in 1900, Tuck was the first institution to offer a master's degree in the field of business administration

MEd Secondary Education

Founded in 1791, University of Vermont is the fifth oldest university in New England (after Harvard, Yale, Dartmouth and Brown). UVM is fully accredited by the New England Association of Schools and Colleges (NEASC). Called UVM for Universitas Viridis Montis, Latin for "University of the Green Mountains."

Amherst College educates men and women of exceptional potential from all backgrounds so that they may seek, value, and advance knowledge, engage the world around them, and lead principled lives of consequence. Amherst brings together the most promising students, whatever their financial need, in order to promote diversity of experience and ideas within a purposefully small residential community. Working with faculty, staff, and administrators dedicated to intellectual freedom and the highest standards of instruction in the liberal arts, Amherst undergraduates assume substantial responsibility for undertaking inquiry and for shaping their education within and beyond the curriculum. Amherst College is committed to learning through close colloquy and to expanding the realm of knowledge through scholarly research and artistic creation at the highest level. Its graduates link learning with leadership—in service to the College, to their communities, and to the world beyond.

Career History
Vice President, Marketing & Corporate Development
2012 - 2016

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Director-Product Management & Marketing
2010 - 2012

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines, as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory on the production line and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Product Manager
2004 - 2007

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Julien Bradley. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Julien Bradley's profile does not indicate a business or promotional relationship of any kind between RelSci and Julien Bradley.